跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOVOMIN SYRUP 15 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
NOVOMIN SYRUP 15 mg/5 ml
Approved
THERAPEUTIC
NOVOMIN SYRUP 15 mg/5 ml
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 4, 1989
Approval ID
eb71bd0917d951ff
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
eb71bd0917d951ff
Drug Name
NOVOMIN SYRUP 15 mg/5 ml
Product Name
NOVOMIN SYRUP 15 mg/5 ml
Approval Number
SIN03550P
Approval Date
1989-07-04
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
A04AD
Atc Item Name
其它镇吐药
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
DIMENHYDRINATE
15 mg/5 ml
DIMENHYDRINATE
15 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 4, 1989
Approval ID
eb71bd0917d951ff
Type
Therapeutic
Back to HSA Approvals